Gene Query: CSF2RA

Dataset Description Geneva Score
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 56.18
Next generation sequencing of small RNAs isolated from exosomes in human semen 50.91
miR-93 Targets in Human Endothelial Cells 45.42
Transcriptome analysis of kidney organoids 44.52
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 43.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 40.81
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 31.42
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 29.76
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 29.02
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 25.49
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 24.18
Pharmacologic inhibition of STAT5 in AML 22.74
Transcriptome analysis of virus infected tissues 22.56
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 21.76
Sensing self and nonself circular RNAs 19.68
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 19.22
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 17.39
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 16.8
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 14.91
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 14.86
Role of cervicovaginal microbiota in genital inflammation 14.34
Generation and functional characterization of MDSC-like cells 14.32
Fbxo32 mediated gene expression program underlies EMT and metastasis 14.15
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 14.06
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 14.06
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 13.67
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.6
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 13.09
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 12.9
Transcriptome analysis in Neobractatin treated cells 12.49
CircRNAome diversity in human mature B-cells, T-cells and monocytes 12.3
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 12.3
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 12.3
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 11.59
Microglia innatly develop within cerebral organoids 11.52
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 10.99
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 10.99
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 10.63
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 10.44
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 10.44
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 10.44
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 9.93
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.92
Transcriptome wide analysis of classically and alternatively activated macrophages 9.63
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 9.48
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.42
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.42
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 9.35
RNA-sequencing of formalin fixed human primary melanoma tissue 8.94
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.91
Single cell transcriptome of peritoneal cells 8.85
Trascriptome of thyroid cancer-induced macrophages 8.77
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 8.75
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 8.69
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 8.64
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 8.6
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.43
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.43
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.97
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.81
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 7.69
Genome-wide analysis of the Integrator complex (HTS) 7.64
Genome-wide analysis of the Integrator complex 7.64
snRNAs as regulators of alternative splicing 7.63
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 7.36
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 7.36
AMPK signaling for naïve pluripotency 7.29
AMPK signaling for naïve pluripotency [Hs] 7.29
RNA-seq of cells with TET1 knockout 7.14
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.14
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.02
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 6.89
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 6.85
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 6.83
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.77
Identification of renal resident macrophages across species 6.58
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 6.57
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 6.56
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.5
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.5
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.44
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 6.42
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.37
ZIKV infection of monocytes activates inflammasome pathways 6.34
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.27
Transcription control by the ENL YEATS domain in acute leukemia 6.27
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.25
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.25
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 6.22
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 6.14
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 5.99
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.88
T47D RNA-seq and ChrRNA-seq data 5.88
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.81
RNA-seq analysis of AML cells in response to ASLAN003 5.76
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 5.75
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 5.67
A map of gene expression in neutrophil-like cell lines 5.67
Transcriptome of human white and brown adipose tissue biopsies 5.65
Genome-wide mapping of TEL-AML1 targets in acute leukemia 5.64
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.51
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.5
Dysregulated immune system networks in war veterans with PTSD 5.47
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.47
Reprogrammed myeloid cell transcriptomes in NSCLC 5.45
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.39
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 5.36
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 5.36
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 5.35
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.33
Effect of Hotair overexpression in human breast cancer cell lines 5.3
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.25
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 5.25
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 5.24
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 5.23
Accurate annotation of human protein-coding small open reading frames 5.21
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 5.13
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 5.11
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.09
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.08
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.96
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.92
Inhibition of TNBC metastasis by Gpx1 4.87
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 4.81
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 4.64
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 4.61
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 4.61
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 4.58
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.54
Transcriptome analysis of peripheral blood monocytes 4.48
Effects of rFVIIIFc on human macrophages 4.48
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 4.47
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 4.44
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 4.44
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.39
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 4.37
Metastasis in triple-negative breast cancer 4.28
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 4.28
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 4.24
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 4.22
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 4.22
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 4.19
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 4.17
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 4.17
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.14
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 4.12
Identification of renal resident macrophages across species [C1] 4.09
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.02
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 4.02
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 4.0
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 4.0
Leucegene: AML sequencing (part 6) 3.98
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 3.95
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 3.94
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.94
RNA m5C Methylation in breast cancer using MeRIP-Seq 3.93
METTL3 and WTAP 3.91
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.91
Targeting MTHFD2 in Acute Myeloid Leukemia 3.88
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 3.83
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 3.83
RNA-seq of naive and primed ES cells 3.83
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 3.79
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 3.79
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.77
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.73
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.7
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.62
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.59
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.59
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 3.57
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.5
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.5
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.49
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 3.47
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 3.46
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.45
Transcriptional profiling of microglia; current state of the art and future perspectives 3.45
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 3.43
oxLDL exposed trained monocytes 3.33
Transcriptomes of oxLDL exposed trained monocytes 3.33
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.28
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.27
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.27
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.27
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.21
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 3.2
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 3.18
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.16
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.14
Capturing the Interactome of Newly Transcribed RNA 3.14
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.14
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.12
RNA-seq of CD33 KO and control HSPCs 3.06
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 3.01
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.99
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.98
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 2.98
Transcriptome of diurnal human blood neutrophils 2.95
Transcriptional profile in human S. haematobium infection 2.95
NAPRT activation of macrophages 2.93
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.84
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.81
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.81
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 2.81
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.77
Reassessment of Exosome Composition 2.77
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.75
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 2.75
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.74
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 2.73
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 2.73
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.69
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.69
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.69
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 2.68
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.65
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.65
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.63
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.62
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 2.62
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 2.61
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 2.61
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.6
TGF-β promotes genomic instability after loss of RUNX3 2.57
RNA-Seq and expression data from human adipose tissue 2.56
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.56
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.56
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.55
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 2.54
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 2.54
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.54
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.51
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.48
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.48
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.48
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 2.48
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.46
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.46
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.45
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 2.45
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.44
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.44
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 2.44
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.39
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.39
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.39
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.39
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 2.37
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.37
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 2.36
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 2.36
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.32
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.31
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.3
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.3
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 2.29
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 2.29
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.28
iPSC-Derived Cholangiocytes 2.28
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.28
Transcriptomes of human monocytes after ex vivo exposure to uric acid 2.25
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.25
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.24
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.24
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.24
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 2.22
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.22
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.21
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 2.17
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 2.17
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.17
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.16
Effect of FGF13 depletion on the H460 cell line 2.14
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.05
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 2.03
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.02
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
Triple vectors expand AAV transfer capacity in the retina 1.99
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.99
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.99
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.98
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 1.97
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 1.97
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.97
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.97
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.95
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.95
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.95
Intron retention induced by microsatellite expansions as a disease biomarker. 1.94
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.94
Expression patterns in chronic thromboembolic pulmonary hypertension 1.92
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.92
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.91
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.89
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.87
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.87
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.87
Single-Cell Genotyping of Transcriptomes 1.8
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.8
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.78
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.78
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 1.77
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.76
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.75
quanTIseq: quantifying immune contexture of human tumors 1.75
ML29755 RNA-seq data 1.71
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.7
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.69
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.68
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.67
Gene expression profile of human placenta from T. Cruzi infected mothers 1.66
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.63
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.61
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.6
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 1.6
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 1.57
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 1.56
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.54
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.52
High-throughput sequencing of PROMPT-enriched samples. 1.43
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.43
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.42
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.41
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.41
Transcriptome Profiling of Human Primary Monocytes 1.4
Macrophage Ad5f35 M2 Challenge 1.4
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.39
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.39
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.38
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.36
TT-Seq captures the human transient transcriptome 1.35
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.35
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.35
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.33
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 1.32
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 1.32
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 1.28
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 1.28
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.26
Proteomics identifies a marker signature of MAPKi resistance in melanoma 1.22
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.22
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.21
MAIT cell RNA sequencing 1.17
Molecular Criteria for Defining the Naive Human Pluripotent State 1.17
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 1.16
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 1.16
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.15
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 1.15
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.11
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.11
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.1
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.1
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.1
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.08
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.08
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.08
RNA-seq of primary patient AML samples 1.07
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 1.05
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.04
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.03
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.03
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.02
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.01
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.01
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.01
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.0
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.0
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.0
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.97
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.97
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.95
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.94
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.93
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.92
Enhancer activation during EGF response 0.92
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 0.9
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.9
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.89
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.89
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.89
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.88
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.88
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.87
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.86
Transcriptome analysis of CNS leukemia 0.86
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.86
RNA polymerase in pre-B-ALL cell lines 0.84
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.84
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.84
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.84
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.82
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.81
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.8
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.8
Interphase condensins regulate ligand-depedent enhancer activation 0.8
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.79
RNA-seq analysis of the human fetal kidney. 0.78
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.78
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.78
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.77
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 0.76
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.75
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.73
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.73
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.72
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.72
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.72
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.72
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.7
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.69
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.69
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.69
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.69
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.69
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.68
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.68
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.62
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.62
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.61
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 0.61
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.61
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 0.61
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.59
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.58
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.58
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.58
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.57
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.56
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.56
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 0.56
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.55
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.54
Transcriptomic analysis of human macrophages in 3D 0.54
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.54
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.54
Gene expression analysis of breast cancer cell-lines 0.54
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.53
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.53
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.52
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.5
LncRNA expression profiling of ischemic stroke patients 0.49
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.48
Specific molecular signatures underlie response to decitabine in CMML 0.48
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.48
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.47
Macrophage Ad5f35 PhenoMap 0.44
A single-cell transcriptome atlas of the human pancreas 0.43
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.43
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.43
Epigenome regulation during epidermal lineage commitment 0.42
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.41
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.39
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.39
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.37
Transcriptome analysis of BAP1 knockout and restoration 0.37
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.36
Anti-inflammatory effect of indoleacrylic acid (IA) 0.35
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.35
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.35
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.33
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 0.32
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.3
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.28
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.28
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.27
RNA-seq data 0.27
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.26
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 0.25
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.23
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.23
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.23
Expression analysis of the TAF1 syndrome 0.23
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.22
RNAseq analysis of ruxolitinib treated breast cancers 0.22
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.21
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.21
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.2
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 0.2
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.19
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.18
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.13
Deep RNA sequencing of the human placental transcriptome 0.13
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.12
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.1
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.1
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.09
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.07
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.06
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.05
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.03
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.03
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 0.03
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.03
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.03
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.02
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.01
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation